{"id":4600,"date":"2020-05-06T17:21:04","date_gmt":"2020-05-06T15:21:04","guid":{"rendered":"https:\/\/www.anderapartners.com\/?p=4600"},"modified":"2020-10-07T19:12:02","modified_gmt":"2020-10-07T17:12:02","slug":"appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.anderapartners.com\/en\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/","title":{"rendered":"Appointment of Michael H. Carrel as chairman of the Axonics board of directors."},"content":{"rendered":"

\"\"<\/p>\n

Apr. 29, 2020– Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (\u201cSNM\u201d) devices for the treatment of urinary and bowel dysfunction, announced today the appointment of Michael H. Carrel as chairman of the Axonics board of directors. Concurrent with this appointment, Raphael Wisniewski, who has served as chairman of Axonics since the Company\u2019s inception in late 2013, is retiring and will not stand for re-election at the 2020 annual meeting of stockholders.<\/p>\n

Mr. Carrel has been a member of the board of directors of Axonics since February 2019. He currently serves as president, chief executive officer and board member of AtriCure, Inc. (NASDAQ: ARTC) and has been in this role for over seven years. AtriCure develops and markets medical devices for the treatment of atrial fibrillation and related conditions. Under Mr. Carrel\u2019s leadership, AtriCure\u2019s revenue was $231 million in 2019, up from $72 million in 2012. Mr. Carrel\u2019s 25-year career includes successful leadership roles in global organizations in the healthcare and technology industries.<\/p>\n

Raymond W. Cohen, CEO of Axonics commented, \u201cOn behalf of all Axonics stakeholders, I would like to acknowledge Raphael for his many contributions and valuable service to our organization since our inception. Raphael\u2019s investment firm, Andera Partners, based in Paris, France, manages over \u20ac2 billion in assets and was the lead investor in a number of Axonics\u2019 private financing rounds prior to the Company\u2019s IPO in November 2018.<\/strong> <\/em>We owe Raphael a debt of gratitude for recognizing the opportunity in Axonics and providing steady Board leadership during our transition to a commercial stage company.\u201d<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Apr. 29, 2020– Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (\u201cSNM\u201d) devices for the treatment of urinary and bowel dysfunction, announced today the appointment of Michael H. Carrel as chairman of the Axonics board of directors. Concurrent with this appointment, Raphael Wisniewski,…<\/p>\n","protected":false},"author":2,"featured_media":3817,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[123],"class_list":["post-4600","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biodiscovery-en"],"acf":[],"yoast_head":"\nAppointment of Michael H. Carrel as chairman of the Axonics board of directors. - ANDERA PARTNERS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Appointment of Michael H. Carrel as chairman of the Axonics board of directors. - ANDERA PARTNERS\" \/>\n<meta property=\"og:description\" content=\"Apr. 29, 2020– Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (\u201cSNM\u201d) devices for the treatment of urinary and bowel dysfunction, announced today the appointment of Michael H. Carrel as chairman of the Axonics board of directors. Concurrent with this appointment, Raphael Wisniewski,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"ANDERA PARTNERS\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-06T15:21:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-10-07T17:12:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/02\/Axonics.png\" \/>\n\t<meta property=\"og:image:width\" content=\"138\" \/>\n\t<meta property=\"og:image:height\" content=\"86\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nicolas Delsert\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nicolas Delsert\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/\"},\"author\":{\"name\":\"Nicolas Delsert\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\"},\"headline\":\"Appointment of Michael H. Carrel as chairman of the Axonics board of directors.\",\"datePublished\":\"2020-05-06T15:21:04+00:00\",\"dateModified\":\"2020-10-07T17:12:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/\"},\"wordCount\":280,\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/02\/Axonics.png\",\"articleSection\":[\"andera Life Sciences\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/\",\"name\":\"Appointment of Michael H. Carrel as chairman of the Axonics board of directors. - ANDERA PARTNERS\",\"isPartOf\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/02\/Axonics.png\",\"datePublished\":\"2020-05-06T15:21:04+00:00\",\"dateModified\":\"2020-10-07T17:12:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#primaryimage\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/02\/Axonics.png\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/02\/Axonics.png\",\"width\":138,\"height\":86},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.anderapartners.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Appointment of Michael H. Carrel as chairman of the Axonics board of directors.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#website\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"name\":\"ANDERA PARTNERS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#organization\",\"name\":\"Andera Partners\",\"url\":\"https:\/\/www.anderapartners.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"contentUrl\":\"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg\",\"width\":107,\"height\":44,\"caption\":\"Andera Partners\"},\"image\":{\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c\",\"name\":\"Nicolas Delsert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g\",\"caption\":\"Nicolas Delsert\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Appointment of Michael H. Carrel as chairman of the Axonics board of directors. - ANDERA PARTNERS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Appointment of Michael H. Carrel as chairman of the Axonics board of directors. - ANDERA PARTNERS","og_description":"Apr. 29, 2020– Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (\u201cSNM\u201d) devices for the treatment of urinary and bowel dysfunction, announced today the appointment of Michael H. Carrel as chairman of the Axonics board of directors. Concurrent with this appointment, Raphael Wisniewski,...","og_url":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/","og_site_name":"ANDERA PARTNERS","article_published_time":"2020-05-06T15:21:04+00:00","article_modified_time":"2020-10-07T17:12:02+00:00","og_image":[{"width":138,"height":86,"url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/02\/Axonics.png","type":"image\/png"}],"author":"Nicolas Delsert","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nicolas Delsert","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/"},"author":{"name":"Nicolas Delsert","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c"},"headline":"Appointment of Michael H. Carrel as chairman of the Axonics board of directors.","datePublished":"2020-05-06T15:21:04+00:00","dateModified":"2020-10-07T17:12:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/"},"wordCount":280,"publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/02\/Axonics.png","articleSection":["andera Life Sciences"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/","url":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/","name":"Appointment of Michael H. Carrel as chairman of the Axonics board of directors. - ANDERA PARTNERS","isPartOf":{"@id":"https:\/\/www.anderapartners.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/02\/Axonics.png","datePublished":"2020-05-06T15:21:04+00:00","dateModified":"2020-10-07T17:12:02+00:00","breadcrumb":{"@id":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#primaryimage","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/02\/Axonics.png","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2018\/02\/Axonics.png","width":138,"height":86},{"@type":"BreadcrumbList","@id":"https:\/\/www.anderapartners.com\/fr\/appointment-of-michael-h-carrel-as-chairman-of-the-axonics-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.anderapartners.com\/en\/"},{"@type":"ListItem","position":2,"name":"Appointment of Michael H. Carrel as chairman of the Axonics board of directors."}]},{"@type":"WebSite","@id":"https:\/\/www.anderapartners.com\/fr\/#website","url":"https:\/\/www.anderapartners.com\/fr\/","name":"ANDERA PARTNERS","description":"","publisher":{"@id":"https:\/\/www.anderapartners.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.anderapartners.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.anderapartners.com\/fr\/#organization","name":"Andera Partners","url":"https:\/\/www.anderapartners.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","contentUrl":"https:\/\/www.anderapartners.com\/wp-content\/uploads\/2020\/08\/logo-white.svg","width":107,"height":44,"caption":"Andera Partners"},"image":{"@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/dce1d4a32f2d85f191a44527e202942c","name":"Nicolas Delsert","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.anderapartners.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fca7b29302058c85588bc6bc3db9bd1e?s=96&d=mm&r=g","caption":"Nicolas Delsert"}}]}},"_links":{"self":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/4600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/comments?post=4600"}],"version-history":[{"count":0,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/posts\/4600\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/media\/3817"}],"wp:attachment":[{"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/media?parent=4600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.anderapartners.com\/en\/wp-json\/wp\/v2\/categories?post=4600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}